Location History:
- Freemont, CA (US) (2021)
- San Jose, CA (US) (2022)
- Fremont, CA (US) (2022 - 2023)
Company Filing History:
Years Active: 2021-2023
Title: Weidong Jiang: Innovator in Antibody Research
Introduction
Weidong Jiang stands out as a notable inventor in the field of biotechnology, particularly known for his contributions to antibody research. Residing in Fremont, California, he has garnered recognition for his innovative work that spans multiple patents, ultimately contributing to advancements in therapeutic treatments.
Latest Patents
Jiang's latest patents highlight his expertise in anti-PD-1 and anti-PD-L1 antibodies. His patent on anti-PD-1 antibodies offers comprehensive methodologies for providing these antibodies and their antigen-binding fragments. Additionally, it includes isolated nucleic acid molecules encoding the antibodies, along with related expression vectors and host cells. The patent further details methods for creating these antibodies and emphasizes their pharmaceutical applications in treating various diseases. Similarly, his patent concerning anti-PD-L1 antibodies encompasses variants and mutants, reinforcing his commitment to enhancing therapy options in the biomedical field.
Career Highlights
Weidong Jiang's career is marked by his association with Shanghai Henlius Biotech Inc., an organization focused on the development of innovative biologics. His extensive patent portfolio, comprising five patents, reflects his profound impact on the industry. Each invention signifies not just technological advancement but also the potential to improve patient outcomes through targeted antibody therapies.
Collaborations
Throughout his career, Jiang has collaborated with notable professionals in his field, including Pei-Hua Lin and Chi-Ling Tseng. These partnerships reflect a collaborative spirit that is essential for fostering innovation and advancing scientific understanding in biomedicine.
Conclusion
In summary, Weidong Jiang is a distinguished inventor whose work in developing anti-PD-1 and anti-PD-L1 antibodies has significant implications for therapeutic applications. His contributions, evident through his patents and collaborative efforts, showcase his commitment to innovation within the biotechnology sector. As advancements in antibody therapies continue to evolve, Jiang's role as an inventor offers promising prospects for future medical breakthroughs.